Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | 2-(4-Bromophenyl)indolizine | HCID 346940 | — |
| Reactant | 2-(Dicyclohexylphosphino)-2'-(dimethylamino)biphenyl | HCID 2734217 | — |
| Catalyst | Dichlorobis(triphenylphosphine)palladium | HCID 6102075 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | HCID 67107533 | HCID 67107533 | 24.4% |
Reaction Steps
To 2-(4-bromo-phenyl)-indolizine (1.2 g, 4.42 mmol) in toluene (8 mL) was added cesium carbonate (4.3 g, 13.24 mmol) and morpholine (1.15 mL, 13.24 mmol). To this was added a mixture of bis-(triphenylphosphine)-palladium (II) chloride (120 mg) and 2-dicyclohexylphosphino-2′-(N,N′-dimethylamino)biphenyl (150 mg) in toluene (10 mL). The reaction mixture was degassed for 15 min and then refluxed for 16 h under an atmosphere of argon. The cooled reaction mixture was concentrated in vacuo and the residue dissolved in dichloromethane. The organic layer was washed with water and brine solution (×2), dried over sodium sulfate, filtered and concentrated. The crude compound was purified by column chromatography over silica gel (60-120 mesh) with 80% chloroform/petroleum ether to afford 2-(4-morpholin-4-yl-phenyl)-indolizine (300 mg, 24%) as a solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08604029B2 |
|---|
| Source dataset | uspto-grants-2013_12 |
|---|
| ORD ID | ord-89f47e201e3749f4ad4bfbb95fd460c7 |
|---|
| Source note | uspto-grants-2013_12 |
|---|